Co-Diagnostics Confirms Flu Test Performance Against This Season’s H3N2 Strain
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
Latest Articles
Editor's Top Picks
Blood Test Shows Obesity Speeds Alzheimer’s Development
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Meta-Analysis Backs TissueCypher as Strong Predictor of Barrett’s EsophagusProgression
The study consolidating data from six published studies confirms the test outperforms traditional pathology or clinical factors alone in identifying esophageal cancer risk.
Equipment & Supply Spotlight
Co-Diagnostics to Present Portable PCR Platform with AI Integration
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
News, Know-How & Standards
Disease Detection & Understanding
Cell-Free DNA Test May Identify Immunotherapy Adverse Events Earlier
Johns Hopkins researchers found the blood test detected multiorgan tissue damage in patients experiencing immune-related adverse events from checkpoint inhibitor therapy.
